OTCMKTS:WILYY Demant A/S (WILYY) Stock Price, News & Analysis $28.38 -0.44 (-1.51%) As of 11/9/2026 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and TrendsShort Interest About Demant A/S Stock (OTCMKTS:WILYY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Demant A/S alerts:Sign Up Key Stats Today's Range$28.34▼$28.3850-Day Range$22.65▼$28.9552-Week Range$13.45▼$29.41Volume4,553 shsAverage Volume655 shsMarket Capitalization$12.02 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Demant A/S is a Denmark-based hearing healthcare company that develops and sells hearing aids, audiological diagnostic equipment, and related services. Its product portfolio includes hearing aids under brands such as Oticon and Bernafon, as well as equipment for hearing and balance assessment through Interacoustics. The company also operates hearing care businesses that provide hearing tests, fittings, and ongoing support to consumers. Through its products and services, Demant serves hearing care professionals and customers in markets around the world. Demant traces its origins to 1904, when Hans Demant established a business to help his wife, who had hearing loss. The company was formerly known as William Demant Holding and is headquartered in Denmark.AI Generated. May Contain Errors. Read More Demant A/S Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreWILYY MarketRank™: 1.954912977935 of 5 starsDemant A/S scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingModerate Buy Consensus RatingDemant A/S has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 1 strong buy rating, 1 buy rating, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageDemant A/S has only been the subject of 1 research reports in the past 90 days.Read more about Demant A/S's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth19.09% Earnings GrowthEarnings for Demant A/S are expected to grow by 19.09% in the coming year, from $1.10 to $1.31 per share.Price to Book Value per Share RatioDemant A/S has a P/B Ratio of 8.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Demant A/S has been sold short.Short Interest Ratio / Days to CoverDemant A/S has a short interest ratio ("days to cover") of 0.18, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Demant A/S has recently increased by 209.52%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDemant A/S does not currently pay a dividend.Dividend GrowthDemant A/S does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.74 News SentimentDemant A/S has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Demant A/S this week, compared to 0 articles on an average week. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Demant A/S insiders have not sold or bought any company stock.Percentage Held by InstitutionsDemant A/S has minimal institutional ownership at this time.Read more about Demant A/S's insider trading history. Receive WILYY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Demant A/S and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WILYY Stock News HeadlinesTranscript : Demant A/S, Q3 2026 Interim Management Statement Call, Nov 04, 2026November 4, 2026 | marketscreener.comMDemant: A good Q3, a successful launch and a market reboundNovember 4, 2026 | marketscreener.comMYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. | Profits Run (Ad)Demant A/S Reiterates Earnings Guidance for the Year 2026November 4, 2026 | marketscreener.comMDemant Q3 Revenue Improves On Strong Momentum In Hearing Aids, AcquisitionNovember 4, 2026 | rttnews.comDemant's final third-quarter figures in line with preliminary releaseNovember 3, 2026 | marketscreener.comMConsensus Price Target for Demant A Raised 11.40% to € 46,25October 23, 2026 | msn.comAlphaValue/Baader Europe Downgrades Demant to ReduceOctober 14, 2026 | marketscreener.comMSee More Headlines WILYY Stock Analysis - Frequently Asked Questions How have WILYY shares performed this year? Demant A/S's stock was trading at $16.39 at the start of the year. Since then, WILYY shares have increased by 73.1% and is now trading at $28.3750. How do I buy shares of Demant A/S? Shares of WILYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Demant A/S own? Based on aggregate information from My MarketBeat watchlists, some other companies that Demant A/S investors own include Gentex (GNTX), Johnson & Johnson (JNJ), Akamai Technologies (AKAM), American Assets Trust (AAT), ABM Industries (ABM), AAR (AIR) and AMETEK (AME). Company Calendar Today11/09/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:WILYY Previous SymbolNASDAQ:WILYY CIKN/A Webwww.demant.com Phone(453) 917-7300Fax45-3927-8900Employees26,704Year Founded1904Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.48 billion Price / Sales3.46 Cash Flow$0.86 per share Price / Cash Flow32.94 Book Value$3.51 per share Price / Book8.08Miscellaneous Outstanding Shares423,510,000Free FloatN/AMarket Cap$12.02 billion OptionableNot Optionable Beta1.19 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:WILYY) was last updated on 11/9/2026 by MarketBeat.com Staff. From Our PartnersEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIPO mania is back - here's the income play I'm watching closelySpaceX, Anthropic, and OpenAI are leading a new wave of blockbuster IPOs. Tim Plaehn found a quiet fund that l...Investors Alley | SponsoredIntel Shares Jumped 177% After Elon Musk's DealElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | SponsoredBlack Friday Bombshell (for traders)For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWe flagged Marvell at $80. It's up 251%.On Feb. 7, 2026, Street Sheet Research members saw Marvell (NASDAQ: MRVL) at $80.28, with a $118 target from N...The Street Sheet | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Demant A/S Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Demant A/S With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
